DAX 15.912 0,7%  MDAX 34.340 0,6%  Dow 34.715 -0,9%  Nasdaq 14.846 -1,3%  Gold 1.839 0,0%  TecDAX 3.591 1,8%  EStoxx50 4.300 0,7%  Nikkei 27.773 1,1%  Dollar 1,1313 0,0%  Öl 87,5 -0,3% 

Aktionärsstruktur

Inhaber in %
Freefloat 99,92
Baillie Gifford & Co. 5,98
T. Rowe Price International Ltd. 4,95
RP Management LLC (Investment Management) 3,91
Artisan Partners LP 2,95
Invesco Advisers, Inc. 2,90
Norges Bank Investment Management 2,82
Fidelity Management & Research Co. LLC 2,81
Vanguard Health Care Fund 2,76
Government Pension Fund - Global (The) 2,44
T Rowe Price International Stock Fund 2,22
Artisan International Small-Mid Fund 1,98
Vanguard International Growth Fund 1,94

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2017 2018 2019 2020
Personal am Ende des Jahres 326 329 426 615
Umsatz pro Mitarbeiter in Mio. EUR 0,20 0,23 0,17 0,53

Bilanz (in Mio. EUR) - Aktiva

2017 2018 2019 2020
Summe Umlaufvermögen 341 389 304 1.207
Summe Anlagevermögen 359 488 437 940
Summe Aktiva 415 539 496 1.660

Bilanz (in Mio. EUR) - Passiva

2017 2018 2019 2020
Gesamtverschuldung/ -verbindlichkeiten 0 0 43 318
Summe Fremdkapital 57 50 102 1.038
Summe Eigenkapital 359 488 395 621
Summe Passiva 415 539 496 1.660

Adresse

Semmelweisstrasse 7, 82152 Planegg
Telefon +49 (89) 89927-0
Fax +49 (89) 89927-222
Internet http://www.morphosys.de

Management

Armin Weidmann
Head-Compliance & Quality Assurance
Barbara Krebs-Pohl
Head-Business Development & Portfolio Management
Beate Diefenbach-Streiber
Director-Human Resources & Business Partner
Charlotte Lohmann
Senior Vice President & General Counsel
George S. Golumbeski
Deputy Chairman-Supervisory Board
Günter Wellnhofer
Head-Technical Operations
Harald Watzka
Head-Alliance Management
Jean-Paul Kress
CEO & Chairman-Management Board
Julia Neugebauer
Senior Director-Investor Relations
Klaus de Wall
Head-Accounting & Tax
Krisja Vermeylen
Member-Supervisory Board
Lara Smith-Weber
Senior VP-Controlling & Internal Controlling
Malte Peters
Chief Research & Development Officer
Marc Cluzel
Chairman-Supervisory Board
Maria Castresana
Senior VP & Global Head-Human Resources
Martin Clark
Head-Purchasing & Logistics
Michael Brosnan
Member-Supervisory Board
Ralf Ostendorp
Senior VP, Head-Protein Sciences & CMC
Sharon Evelyn Curran
Member-Supervisory Board
Sung H. Lee
Chief Financial Officer
Wendy S. Johnson
Member-Supervisory Board